These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 29069359

  • 1. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L, ARISTOTLE and RE-LY Investigators.
    Eur Heart J; 2018 Feb 07; 39(6):477-485. PubMed ID: 29069359
    [Abstract] [Full Text] [Related]

  • 2. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
    Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L.
    Circulation; 2018 Oct 16; 138(16):1666-1676. PubMed ID: 29871978
    [Abstract] [Full Text] [Related]

  • 3. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L, ARISTOTLE and RE-LY Investigators.
    Lancet; 2016 Jun 04; 387(10035):2302-2311. PubMed ID: 27056738
    [Abstract] [Full Text] [Related]

  • 4. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
    Benz AP, Hijazi Z, Lindbäck J, Connolly SJ, Eikelboom JW, Oldgren J, Siegbahn A, Wallentin L.
    Circulation; 2021 May 11; 143(19):1863-1873. PubMed ID: 33849281
    [Abstract] [Full Text] [Related]

  • 5. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
    Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L.
    J Am Heart Assoc; 2017 Jun 23; 6(6):. PubMed ID: 28645934
    [Abstract] [Full Text] [Related]

  • 6. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L, ARISTOTLE and STABILITY Investigators.
    Eur Heart J; 2016 May 21; 37(20):1582-90. PubMed ID: 26920728
    [Abstract] [Full Text] [Related]

  • 7. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L, RE-LY and ARISTOTLE Investigators.
    Circulation; 2016 Nov 29; 134(22):1697-1707. PubMed ID: 27569438
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB.
    J Am Coll Cardiol; 2013 Jun 04; 61(22):2274-84. PubMed ID: 23563134
    [Abstract] [Full Text] [Related]

  • 9. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
    Haller PM, Jarolim P, Palazzolo MG, Bellavia A, Antman EM, Eikelboom J, Granger CB, Harrington J, Healey JS, Hijazi Z, Patel MR, Patel SM, Ruff CT, Wallentin L, Braunwald E, Giugliano RP, Morrow DA.
    J Am Coll Cardiol; 2024 Oct 15; 84(16):1528-1540. PubMed ID: 39230543
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
    Pol T, Hijazi Z, Lindbäck J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L.
    Open Heart; 2021 Mar 15; 8(1):. PubMed ID: 33741689
    [Abstract] [Full Text] [Related]

  • 11. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A, ARISTOTLE Investigators.
    Circulation; 2014 Nov 18; 130(21):1847-58. PubMed ID: 25294786
    [Abstract] [Full Text] [Related]

  • 12. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB, ARISTOTLE Investigators.
    J Am Coll Cardiol; 2014 Nov 18; 63(1):52-61. PubMed ID: 24055845
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Alings M, De Caterina R, Eikelboom JW, Ezekowitz MD, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2015943. PubMed ID: 32936298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA.
    Circulation; 2019 Feb 05; 139(6):760-771. PubMed ID: 30586727
    [Abstract] [Full Text] [Related]

  • 16. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
    Hijazi Z, Wallentin L, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Pol T, Yusuf S, Oldgren J, Siegbahn A.
    J Am Heart Assoc; 2020 Dec 15; 9(24):e018984. PubMed ID: 33292046
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.